JPMORGAN CHASE & CO - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 62 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$72,598
-18.9%
43,734
-2.3%
0.00%
Q2 2023$89,52044,760
+11231.6%
0.00%
Q2 2022$0
-100.0%
395
-65.0%
0.00%
Q1 2022$1,000
-87.5%
1,127
-80.7%
0.00%
Q3 2021$8,000
+33.3%
5,847
+352.2%
0.00%
Q1 2021$6,000
-25.0%
1,293
-38.4%
0.00%
Q4 2020$8,0000.0%2,1000.0%0.00%
Q3 2020$8,0002,100
+2000.0%
0.00%
Q2 2020$01000.0%0.00%
Q4 2019$01000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Spire Wealth Management 148,800$158,0000.00%
MEITAV INVESTMENT HOUSE LTD 244,332$257,0000.00%
Phoenix Holdings Ltd. 244,113$259,0000.00%
IHT Wealth Management, LLC 24,000$25,0000.00%
Psagot Value Holdings Ltd. / (Israel) 6,000$6,0000.00%
Virtu Financial LLC 15,199$16,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 41,574$44,0000.00%
Smith, Salley & Associates 12,048$13,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 28,790$31,0000.00%
BANK OF AMERICA CORP /DE/ 5,153$5,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders